These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25224804)

  • 1. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
    Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
    J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC; Ames MK; Werre S; Atkins CE
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
    Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.
    Ames MK; Atkins CE; Lantis AC; zum Brunnen J
    J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320316633897. PubMed ID: 27009288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
    Lantis AC; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
    Am J Vet Res; 2011 Dec; 72(12):1646-51. PubMed ID: 22126693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
    Ames MK; Atkins CE; Eriksson A; Hess AM
    J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs.
    Sayer MB; Atkins CE; Fujii Y; Adams AK; DeFrancesco TC; Keene BW
    J Vet Intern Med; 2009; 23(5):1003-6. PubMed ID: 19737179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs.
    Panteri A; Kukk A; Desevaux C; Seewald W; King JN
    J Vet Pharmacol Ther; 2017 Jan; 40(1):44-56. PubMed ID: 27302598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs.
    Mochel JP; Peyrou M; Fink M; Strehlau G; Mohamed R; Giraudel JM; Ploeger B; Danhof M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP; Fink M; Peyrou M; Soubret A; Giraudel JM; Danhof M
    Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
    Adin D; Atkins C; Wallace G; Klein A
    J Vet Intern Med; 2021 May; 35(3):1245-1254. PubMed ID: 33713485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A; Bagardi M; Stranieri A; Zanaboni AM; Malchiodi D; Borromeo V; Brambilla PG; Locatelli C
    BMC Vet Res; 2021 Jan; 17(1):15. PubMed ID: 33413406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs.
    Ames MK; Atkins CE; Lantis AC; Werre SR
    Am J Vet Res; 2013 Aug; 74(8):1084-90. PubMed ID: 23879846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronobiology and Pharmacologic Modulation of the Renin-Angiotensin-Aldosterone System in Dogs: What Have We Learned?
    Mochel JP; Danhof M
    Rev Physiol Biochem Pharmacol; 2015; 169():43-69. PubMed ID: 26428686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats.
    King JN; Panteri A; Graille M; Seewald W; Friton G; Desevaux C
    BMC Vet Res; 2016 Jun; 12(1):124. PubMed ID: 27338786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of urinary aldosterone measurement in quantitating RAAS activation.
    Atkins CE; Lantis AC; Ames MK; Gardner SY
    J Vet Pharmacol Ther; 2012 Oct; 35(5):512-5; author reply 516-8. PubMed ID: 22966900
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
    Zhang XH; Ma XJ; Luo J; Shao JH; Geng QX; Zhu XL; Tang YS; Xu FY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):592-5. PubMed ID: 15144597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.